Joel Barlan

Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts.

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Dansk Shell A/S operates as energy and petrochemicals companies. The firm produces biofuels. It engages in oil and gas exploration, production, and sale of gasoline and diesel. The company was founded in 1913 and is headquartered in Fredericia, Denmark.

Tytex A/S provides medical textile products. Its products include continence care post surgery, ostomy and hernia, wound dressing and IV fixation, hip protection and pregnancy & nursing. The company was founded in 1971 and is headquartered in Ikast, Denmark.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

Affectis Pharmaceuticals AG discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases. Its products in pipeline include AFC-5128, P2X7 Compounds, AFC-5278 and AFC-08. The company was founded in January 2004 by Florian Holsboer, Wolfgang Wurst and Herbert Stadler and is headquartered in Dortmund, Germany.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark.

H. Lundbeck AS trades pharmaceutical and healthcare products. It provides drugs for the treatment of depression, schizophrenia, alzheimers, and Parkinsons diseases. The company was founded in 1948 and is headquartered in Lysaker, Norway.

Catacap Management A/S (Catacap Management) is a private equity firm founded in 2011byVilhelmEigilHanhPetersen and Jens Jorgen Hanh Petersen. The firm is headquartered in Copehagen, Denamrk.

Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden.

GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland.

HASLE Industries A/S specializes in producing refractory materials for high-temperature industries. The private company is based in Ronne, Denmark. The Danish company offers a range of technical design services, including material selection, drawings, and heat loss calculations, in addition to its refractory product line. HASLE Industries produces a variety of high-grade refractory solutions, such as low cement castables, accessories, and precast elements, including insulating, easy flowing, and gunning versions for optimized installation.

Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA.

Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA.

The Sophocles Group LLC provides investment services. The private company is based in Princeton.

Union Therapeutics A/S operates as a clinical stage pharmaceutical company which focuses on the treatment of inflammatory skin disease. It also centers in the development of molecules exhibiting immunological and microbiological effects. The company is headquartered in Hellerup, Denmark.

Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD.

JBR Pharma, Inc. operates as a virtual pharmaceutical company. The company is headquartered in Plymouth Meeting, PA.

StemMedical A/S provides a cell-enriched fat grafting solution for cosmetic treatments. The company is based in Soborg, Denmark. The Danish company was founded in 2014 by Stig-Frederik Trojahn Kølle.

Transmedica A/S provides patients with specialized treatment. It operates as health care provider, which recruits and sends health workers and agency staff to public and private hospitals in the Scandinavian healthcare sector. The firm's activities are divided into main business units temporary help; private hospitals and clinics; and other health services. It also runs clinics specialized in weight loss surgery, eye surgery, orthopedics, rheumatology, and psychiatry. The company was founded by Karsten Ramløv Svendsen in 1990 and is headquartered in Copenhagen, Denmark.